Abstract | BACKGROUND: MATERIALS AND METHODS: RESULTS: Administration of TJN-331 or captopril prevented elevation of serum creatinine. Histopathological examination after both experimental periods showed that TJN-331 inhibited increases in the mesangial matrix index and the number of nuclei per glomerular cross-section, compared with in untreated ddY mice with IgA nephropathy. TJN-331 prevented increase in glomerular TGF-β1 staining without affecting IgA. In the in vitro study, TJN-331 prevented total TGF-β1 production from splenocytes stimulated with concanavalin A. A neutralizing antibody against TGF-β1 prevented increase in the mesangial matrix index and the number of glomerular cells per cross-sectional area. CONCLUSION: These results suggest that TJN-331 is effective against IgA nephropathy in ddY mice and acts via suppression of TGF-β1 production in glomeruli.
|
Authors | Yayoi Saegusa, Chiharu Sadakane, Junichi Koseki, Yoshihiro Hasegawa, Shoichiro Shindo, Shuichi Takeda, Hiroshi Takeda, Tomohisa Hattori |
Journal | Clinical and experimental nephrology
(Clin Exp Nephrol)
Vol. 14
Issue 6
Pg. 528-35
(Dec 2010)
ISSN: 1437-7799 [Electronic] Japan |
PMID | 20814808
(Publication Type: Journal Article)
|
Chemical References |
- Acrylamides
- N-(3,4-dimethoxyphenethyl)-N-methyl-3-(3-pyridyl)-2-propenamide
- Pyridines
- Transforming Growth Factor beta1
- Concanavalin A
- Creatinine
|
Topics |
- Acrylamides
(pharmacology)
- Animals
- Concanavalin A
(pharmacology)
- Creatinine
(blood)
- Disease Models, Animal
- Glomerular Mesangium
(drug effects, pathology)
- Glomerulonephritis, IGA
(pathology)
- Kidney Glomerulus
(pathology)
- Mice
- Mice, Inbred Strains
- Nephrectomy
- Pyridines
(pharmacology)
- Spleen
(cytology)
- Transforming Growth Factor beta1
(antagonists & inhibitors, biosynthesis)
|